Alnara Pharmaceuticals' Acquisition

Alnara Pharmaceuticals was acquired by Eli Lilly & Co. on July 02, 2010.

Alnara Pharmaceuticals is dedicated to developing and commercializing novel protein therapeutics for the treatment of metabolic diseases. The company's innovative approach focuses on designing effecti…

Articles about Alnara Pharmaceuticals' Acquisition: